$522.04 ISRG Intuitive Surgical (NASDAQ) pre-market 30 Jan 2026: AI surgical growth under watch
ISRG stock opens pre-market at $522.04 on 30 Jan 2026 as investors weigh recent beats and AI-driven clinical tools. Intuitive Surgical, Inc. (ISRG) on NASDAQ remains a leader in robotic surgery and digital procedures, reporting trailing EPS 7.88 and a PE near 64.41. Volume sits at 1,851,332 shares versus an average of 2,114,059, and the stock trades between a 52-week low of $425.00 and high of $609.08. We examine earnings, valuation, technical signals, and how AI initiatives shape the outlook for ISRG stock
ISRG stock snapshot and market context
Intuitive Surgical, Inc. (ISRG) trades on NASDAQ in the United States at $522.04 with market cap about $181.94B. Day range today is $520.24–$529.36, 50-day average $559.74, 200-day average $516.19, and relative volume near 0.98. The company sits in Healthcare, Medical – Instruments & Supplies, where sector strength and elective-surgery cycles drive short-term flows.
ISRG stock earnings and valuation
Latest quarterly results showed EPS of $2.53 and revenue $2.87B, beating consensus; trailing EPS is 7.88. Key valuation metrics: PE 64.41, price/sales 18.08, price/book 10.64, and free cash flow per share 6.40, which keep the stock richly priced versus peers. Analysts’ consensus price target averages $618.52, implying an analyst upside of 18.48% from current levels.
Technical setup and trading signals for ISRG stock
Momentum indicators are mixed: RSI 65.69 (near overbought), MACD histogram modestly positive (MACD 6.08, Signal 5.96), and ADX 22.53 showing a developing trend. Bollinger Bands middle is $566.22 and ATR 11.47, suggesting intraday swings of about $11.47. Short-term traders should watch the 50-day $559.74 resistance and 200-day $516.19 support.
Meyka AI rates ISRG with a score out of 100 and model forecast
Meyka AI rates ISRG with a score of 74.62 out of 100 (B+, BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 1-year target of $605.93, implying 16.07% upside from the current $522.04; forecasts are model-based projections and not guarantees.
AI-driven opportunities and risks affecting ISRG stock
Intuitive’s expansion of digital tools and diagnostic platforms like Ion increases addressable market and recurring revenue. Research & development run-rate is about 13.03% of revenue, supporting product evolution. Risks include high valuation, surgical volumes tied to macro cycles, and regulatory or reimbursement shifts that could pressure margins.
Analyst consensus, insider moves and institutional flows
Sell-side consensus is a Moderate Buy with 16 Buys, 4 Holds and 2 Sells; MarketBeat lists an average target $618.52. Insiders sold ~48,152 shares in recent months, while institutional ownership is 83.64%. Recent fund buys and price-target raises indicate continued confidence among large holders, even as some models flag stretched multiples.
Final Thoughts
Key takeaways on ISRG stock: Intuitive Surgical trades at $522.04 on NASDAQ with a premium multiple (PE 64.41) justified by strong margins (net margin 28.38%) and continued revenue growth. Recent quarterly beats and rising adoption of AI-enabled surgical and diagnostic offerings support multi-year growth. Analysts’ average target $618.52 suggests ~18.48% upside, while Meyka AI’s forecast of $605.93 implies ~16.07% upside versus today. Technicals show near-term resistance around $559.74 and support near $516.19. Investors focused on AI stocks should weigh durable cash generation (free cash flow per share 6.40) and R&D intensity (13.03% of revenue) against valuation risk and macro-sensitive procedure volumes. Meyka AI, our AI-powered market analysis platform, provides the proprietary grade and forecast — these are model outputs and not guarantees. For active traders, watch intra-day volatility metrics like ATR 11.47; for longer-term investors, monitor adoption trends for digital procedures and guidance at the next earnings update.
FAQs
What is the current price and outlook for ISRG stock?
ISRG stock trades at $522.04 pre-market on 30 Jan 2026. Analyst targets average $618.52 and Meyka AI forecasts $605.93 for one year; both imply mid-teens upside but valuation remains elevated.
How did ISRG perform in the latest earnings report?
Intuitive Surgical beat estimates with quarterly EPS $2.53 and revenue $2.87B. Trailing EPS is 7.88 and net margin is 28.38%, supporting growth-oriented ISRG stock narratives.
What are the main risks for ISRG stock investors?
Risks include high valuation (PE 64.41), dependence on elective procedure volumes, potential reimbursement or regulatory changes, and insider selling. These can heighten short-term downside for ISRG stock.
Does Meyka AI give a rating for ISRG stock?
Yes. Meyka AI rates ISRG with a score of 74.62 out of 100 (B+, BUY), based on benchmark, sector, financial growth, key metrics, forecasts and analyst consensus.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
